All News

    FDA Fast Tracks JSKN003 in Ovarian Cancer

    October 30th 2025, 3:00pm

    Article

    The FDA granted fast track designation to JSKN003 in platinum-resistant recurrent epithelial ovarian cancer, primary peritoneal cancer or fallopian tube cancer.

    Keeping Her Hair Helped Her Feel Normal During Breast Cancer Treatment

    October 30th 2025, 1:00pm

    Video

    Scalp cooling helped Maureen Green feel more like herself during chemotherapy, giving her control over her appearance at a time filled with fear and uncertainty.

    With Cancer, 'Your Outlook Will be Significant in Beating this Disease'

    October 29th 2025, 9:00pm

    Article

    My first oncologist got me started with positivity in my cancer journey, which I was, thankfully able to internalize.

    Advancing Research Offers Hope for Patients With Liver Cancer

    October 29th 2025, 8:03pm

    Video

    During Liver Cancer Awareness Month, Dr. Anjana Pillai says more treatment options, growing trials and ongoing research offer hope for patients.

    Breast Cancer Survivor and Nurse Shares Her Story

    October 29th 2025, 7:00pm

    Article

    For Stephanie Wachtel, receiving a diagnosis of triple-positive breast cancer at the age of 23 was life-changing in a number of ways.

    How Breast Cancer Treatment Can Impact Menopause and Fertility

    October 29th 2025, 4:59pm

    Article

    Therapies may affect ovarian function and cause early menopause, and many younger women can still pursue family planning with guidance from their care team.

    FDA Grants Exousia Pro Orphan Drug Designation in Glioma

    October 29th 2025, 4:00pm

    Article

    Exousia Pro, Inc. received orphan drug designation from the FDA for malignant glioma, also known as glioblastoma multiforme or GBM.

    Sharing Insights Into a Multiple Myeloma Journey

    October 29th 2025, 3:00pm

    Video

    CURE contributor Ronald D. Chin received a diagnosis of multiple myeloma in 2017 and has been in remission since 2023.

    What to Know About the FDA Approval of Blenrep for Multiple Myeloma

    October 29th 2025, 1:00pm

    Video

    The FDA has approved Blenrep with BVd as a third-line treatment for relapsed or refractory multiple myeloma.

    Why Should Patients With Breast Cancer Prioritize Wellness?

    October 28th 2025, 9:00pm

    Video

    Dr. Sheldon M. Feldman says patients with breast cancer should accept support and make exercise and wellness priorities during treatment to improve outcomes.